Entrada Therapeutics, Inc.

NASDAQ:TRDA

8.32 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 20.55837.39819.5794.69459.1241.84843.73518.1725.26000000000000
Kosten van de omzet 000.90.90.9340.7360.80.70.5410.5250.50.5000000000
Brutowinst 20.55836.40618.6793.79458.18641.11242.93517.4724.719-0.525-0.5-0.5000000000
Brutowinstmarge 10.9730.9540.990.9840.9820.9820.9610.979000000000000
Onderzoek- en ontwikkelingskosten 32.07432.41431.25731.13527.67427.55522.19126.323.10215.68518.95816.24815.71812.36210.5136.8296.2236.6565.74.3734.373
Algemene en administratieve kosten 10.2749.8599.9719.2369.3998.6527.5328.1697.9389.8946.9787.3346.4336.0983.8513.0812.171.9971.2731.1481.148
Verkoop- en marketingkosten 000000000000000000000
Verkoop-, algemene en administratieve kosten 10.2749.8599.9719.2369.3998.6527.5328.1697.9389.8946.9787.3346.4336.0983.8513.0812.171.9971.2731.1481.148
Overige kosten 000-32.03500000000000000000
Bedrijfskosten 42.34842.27341.22840.37137.07336.20729.72334.46931.0425.57925.93623.58222.15118.4614.3649.918.3938.6536.9735.5215.521
Bedrijfsresultaat -21.79-5.867-21.65853.42321.1134.90514.012-16.2991.322-25.579-25.936-23.582-22.151-18.46-14.364-9.91-8.393-8.653-6.973-5.521-5.521
Bedrijfsresultaat ratio -1.06-0.157-1.1070.5640.3570.1170.32-0.8970.052000000000000
Totaal overige inkomsten en kosten netto 4.4415.1285.7664.3664.2144.2924.0514.2182.6570.950.7990.4030.480.013-0.0660.0090.013-0.02-0.0170.0910.091
Inkomen voor belasting -17.349-0.739-15.89257.78925.3279.19718.063-12.081-3.123-24.629-25.137-23.179-21.671-18.447-14.43-9.901-8.38-8.673-6.99-5.43-5.43
Inkomen voor belasting ratio -0.844-0.02-0.8120.610.4280.220.413-0.665-0.124000000000000
Belastingkosten 0-1.87-1.862.7581.83118.741-17.39813.8473.551-2.425-1.598-0.806-0.96-0.0130000000
Nettowinst -17.3491.131-14.03255.03123.496-9.54435.461-25.928-6.674-22.204-23.539-22.373-20.711-18.434-14.43-9.901-8.38-8.673-6.99-5.43-5.43
Nettowinstmarge -0.8440.03-0.7170.5810.397-0.2280.811-1.427-0.264000000000000
WPA (Winst Per Aandeel) -0.420.028-0.351.610.7-0.291.07-0.78-0.21-0.71-0.75-0.72-0.66-0.89-0.51-0.48-0.41-0.42-0.34-5.18-5.18
Verwaterde WPA -0.420.026-0.351.550.68-0.291.02-0.78-0.21-0.71-0.75-0.72-0.66-0.89-0.51-0.48-0.41-0.42-0.34-5.18-5.18
EBITDA -20.844-4.875-21.65853.42322.0475.64114.012-15.569-5.239-25.053-25.42-23.119-21.761-18.096-14.062-9.658-8.194-8.555-6.883-5.452-5.452
EBITDA ratio -1.014-0.13-1.1070.5640.3730.1350.32-0.857-0.207000000000000